drugset / Trial / NCT06717191
Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan
Phase 4
Completed
296 enrolled
Life for a Child Program, Diabetes Australia
Baqai Institute of Diabetology and Endocrinology · collab
NaSingle-groupOpen-labelTreatment
Summary
This study aimed to determine the effect of introducing Basaglar and insulin pen injection devices on clinical and quality of life (QOL) parameters in children and young adults with type 1 diabetes in Pakistan
Timeline
- Start
- 2022-06-09
- Primary completion
- 2024-06-15
- Completion
- 2024-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | — |